Lineage Cell Therapeutics Inc (AMEX:LCTX) concluded the trading at $0.53 on Wednesday, January 08 with a fall of -8.65% from its closing price on previous day.
Taking a look at stock we notice that its last check on previous day was $0.58 and 5Y monthly beta was reading 1.282 with its price kept floating in the range of $0.53 and $0.567 on the day. Considering stock’s 52-week price range provides that LCTX hit a high price of $1.61 and saw its price falling to a low level of $0.48 during that period. Over a period of past 1-month, stock came subtracting -9.15% in its value.
In contrast, when we review LCTX stock’s current outlook then short term indicators are assigning it an average of 100% Sell, while medium term indicators are categorizing the stock at an average of 100% Sell. Long term indicators are suggesting an average of 100% Sell for it.
Digging deeper we become aware of the PEG ratio of the LCTX stock which is currently positioned at 0. It further provides that stock’s current price level is -0.16% away from its 20-day simple moving average and is -19.79% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 44.94 while volatility remained at 9.82% over the past week which changes to 8.73% when measuring it over the past month. Beta is valued at 1.19, while measure of average true range or ATR is currently at 0.05.
Having a second look at Lineage Cell Therapeutics Inc (AMEX:LCTX) provides that stock’s average daily trading volume for 3 months was 2.19 million, while it jumped to 3280220 when we calculate an average volume for past 10 days. Number of outstanding shares of the stock stood at 220.42 million.
The percentage of outstanding shares held by the insiders is 0.66% while it is 43.59% for the institutional holders. The figures also indicate that as of 2024-10-31, number of stock’s short shares was 15.94 million which implies a short ratio of 35.21. This shows up a 1089.00 of Short Interest in company’s outstanding shares on the day. In October the standing of shares short improved as it was 15.22 million in the previous month. Addition of 5.91% by stock’s current price to its year-to-date value in last trading session is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.
